Index Entries - Covid Index

1536 Results

Title	IS Publication Date
Intravenous injection of COVID-19 mRNA vaccine can induce acute myopericarditis in mouse model	August 18, 2021
Investigating trends in those who experience menstrual bleeding changes after SARS-CoV-2 vaccination	July 15, 2022
Investigation of metallic contaminations found in vector- and mRNA-based COVID-19-”vaccines”: Preliminary Results	March 20, 2022
Is a Mask That Covers the Mouth and Nose Free from Undesirable Side Effects in Everyday Use and Free of Potential Hazards?	April 20, 2021
Is FDA ‘Covering for Pfizer’? Court Orders Agency to Release a Million More Pages of COVID Vaccine Documents	December 9, 2024
Is resistance to Covid-19 vaccination a “problem”? A critical policy inquiry of vaccine mandates for healthcare workers	June 12, 2024
Is the US’s Vaccine Adverse Event Reporting System broken?	November 10, 2023
Is there a Link between the 2021 COVID-19 Vaccination Uptake in Europe and 2022 Excess All-Cause Mortality?	February 21, 2023
It’s time to withdraw the mRNA vaccines	January 9, 2023
Ivermectin as a Potential Addition to the Limited Anti-COVID-19 Arsenal: A Double-Blinded Clinical Trial	April 30, 2024
Ivermectin as a SARS-CoV-2 Pre-Exposure Prophylaxis Method in Healthcare Workers: A Propensity Score-Matched Retrospective Cohort Study	August 26, 2021
Ivermectin as Prophylaxis Against COVID-19 Retrospective Cases Evaluation	December 2020
Ivermectin Could Have Saved Millions of Lives, Why Was It Suppressed	June 20, 2023
Ivermectin for COVID-19 in adults in the community (PRINCIPLE): An open, randomised, controlled, adaptive platform trial of short- and longer-term outcomes	February 29, 2024
Ivermectin for COVID-19: Real-time meta-analysis of 99 studies	November 26, 2020
Ivermectin for Prevention and Treatment of COVID-19 Infection: A Systematic Review, Meta-analysis, and Trial Sequential Analysis to Inform Clinical Guidelines	July / August 2021
Ivermectin in combination with doxycycline for treating COVID-19 symptoms: a randomized trial	May 13, 2021
Ivermectin prophylaxis used for COVID-19 reduces COVID-19 infection and mortality rates: A 220,517-subject, populational-level retrospective citywide observational study	January 2022
Ivermectin Prophylaxis Used for COVID-19: A Citywide, Prospective, Observational Study of 223,128 Subjects Using Propensity Score Matching	January 15, 2022
Ivermectin reduces in vivo coronavirus infection in a mouse experimental model	March 30, 2021
Ivermectin: a multifaceted drug of Nobel prize-honoured distinction with indicated efficacy against a new global scourge, COVID-19	August 3, 2021
Ivermectin: an award-winning drug with expected antiviral activity against COVID-19	October 7, 2020
Jab Injuries Australia
Japanese Professor Upends Ministry of Health: Disband Vax Committee, Investigate All Injuries	December 1, 2022
Johnson & Johnson clinical trial: A Study of Ad26.COV2.S for the Prevention of SARS-CoV-2-Mediated COVID-19 in Adult Participants	First posted August 10, 2020; last update May 6, 2023
Kansas AG sues Pfizer for misleading Kansans on COVID vaccine	June 17, 2024
Kolaviron (Kolaflavanone), apigenin, fisetin as potential Coronavirus inhibitors: In silico investigation	August 4, 2020
Kounis syndrome following COVID-19 vaccination: Clinical manifestations, mechanisms and management	June 19, 2024
Lab Leak - The True Origins of COVID-19	April 18, 2025
Laboratory testing for coronavirus disease (COVID-19) in suspected human cases	March 19, 2020
Large-scale Study of Antibody Titer Decay following BNT162b2 mRNA Vaccine or SARS-CoV-2 Infection	December 31, 2021
Lasting immunity found after recovery from COVID-19	January 26, 2021
Latest statistics on England mortality data suggest systematic mis-categorisation of vaccine status and uncertain effectiveness of Covid-19 vaccination	December 3, 2021
Legal Letter on Behalf of Physicians Regarding Covid-19 Vaccine Injuries (to heads of the DHHS, CDC, and FDA)	October 27, 2021
Less severe course of COVID-19 is associated with elevated levels of antibodies against seasonal human coronaviruses OC43 and HKU1 (HCoV OC43, HCoV HKU1)	February 22, 2021
Lessons Learned from FEMA’s Initial Response to COVID-19	September 21, 2021
Letter from a Los Angeles Psychiatrist to his Patients	February 2022
Letter from Ron Johnson to HHS, FDA and CDC directing them to preserve all records relating to COVID-19 vaccines	November 19, 2024
Letter from Senator Ron Johnson to Lloyd J. Austin III, Secretary of the Department of Defense	February 1, 2022
Letter from US Senators to USAID regarding funding and activities of EcoHealth Alliance	September 14, 2022
Letter of inquiry from the US House Committee on Oversight and Reform to Dr. Kristian Andersen	February 3, 2022
Letter to the Chief Executive of the UK Medicines and Healthcare Products Regulatory Agency: Urgent preliminary report of Yellow Card data up to 26th May 2021	June 9, 2021
Letter to the Editor: Long-Term Prognosis of Patients With Myocarditis Attributed to COVID-19 mRNA Vaccination, SARS-CoV-2 Infection, or Conventional Etiologies	November 5, 2024
Letter to the Editor: Meta-analysis on facemask use in community settings to prevent respiratory infection transmission shows no effect	November 16, 2020
Letter to U.S. Food and Drug Administration, Vaccines and Related Biological Products Advisory Committee in response to “Request for Comments related to consideration of vaccines against SARS-CoV-2”	December 8, 2020
Letter: A retrospective cohort study of methylprednisolone therapy in severe patients with COVID-19 pneumonia	April 28, 2020
Letter: The epidemiological relevance of the COVID-19-vaccinated population is increasing	November 19, 2021
Leveraging epidemiological principles to evaluate Sweden’s COVID-19 response	November 23, 2020
Limitations of models for guiding policy in the COVID-19 pandemic	June 30, 2022
Live virus neutralisation testing in convalescent patients and subjects vaccinated against 19A, 20B, 20I/501Y.V1 and 20H/501Y.V2 isolates of SARS-CoV-2	August 1, 2021

Page 16 of 31